We also saw a similar reprogramming of macrophages in the tumor stroma under these experimental condition, demonstrating that cell autonomous FXa-PAR2 signaling determines TAM phenotypes and that this signaling pathway can be therapeutically targeted by tissue-penetrating oral FXa inhibitors [19]. Here, F10 is linked to neoplasm.